Immunomedics (IMMU) - moderated Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Immunomedics (IMMU) - moderated

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

Recommended by:

To: kdd999 who wrote (38513)	1/7/2017 8:28:18 PM
From: idahoranch1	4 Recommendations of 63291

I've never liked that Goldman Sach's was involved in our bond issue, and then on top of that, they never picked up coverage on the company. So, in effect, they represented the bonds as a good deal for the bond buyers, but not so much the stock of the company. Under current management, the only game being played is the finance game, and the financiers are doing quite well. Another reason this way of doing business has to end.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next